Leverage Shares -3x Short Moderna (MRNA) ETP Securities: Q4 Earnings Insights

Leverage Shares -3x Short Moderna (MRNA) ETP Securities MRNS reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:00 PM.

Here's what investors need to know about the announcement.

Leverage Shares -3x Short Moderna (MRNA) ETP Securities missed estimated earnings by -19.0%, reporting an EPS of $-0.74 versus an estimate of $-0.62.

Revenue was up $28 thousand from the same period last year.

Last quarter the company beat on EPS by $0.05 which was followed by a 6.0% increase in the share price the next day.

Here's a look at Leverage Shares -3x Short Moderna (MRNA) ETP Securities's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.66	-0.72	-0.72	-0.70
EPS Actual	-0.61	-0.61	-0.67	-0.76
Revenue Estimate	6.33M	5.73M	5.88M	5.35M
Revenue Actual	7.34M	6.08M	10.38M	7.16M

To track all earnings releases for Leverage Shares -3x Short Moderna (MRNA) ETP Securities visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar